412 related articles for article (PubMed ID: 34929348)
1. A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer's prevention & treatment.
Mishra A; Wang Y; Yin F; Vitali F; Rodgers KE; Soto M; Mosconi L; Wang T; Brinton RD
Ageing Res Rev; 2022 Feb; 74():101542. PubMed ID: 34929348
[TBL] [Abstract][Full Text] [Related]
2. Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimer's Risk in Female Brain.
Wang Y; Shang Y; Mishra A; Bacon E; Yin F; Brinton R
Sci Rep; 2020 May; 10(1):8528. PubMed ID: 32444841
[TBL] [Abstract][Full Text] [Related]
3. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
4. Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention.
Wu L; Zhang X; Zhao L
J Neurosci; 2018 Jul; 38(30):6665-6681. PubMed ID: 29967007
[TBL] [Abstract][Full Text] [Related]
5. Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition.
Mosconi L; Berti V; Dyke J; Schelbaum E; Jett S; Loughlin L; Jang G; Rahman A; Hristov H; Pahlajani S; Andrews R; Matthews D; Etingin O; Ganzer C; de Leon M; Isaacson R; Brinton RD
Sci Rep; 2021 Jun; 11(1):10867. PubMed ID: 34108509
[TBL] [Abstract][Full Text] [Related]
6. Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.
Ding F; Yao J; Rettberg JR; Chen S; Brinton RD
PLoS One; 2013; 8(11):e79977. PubMed ID: 24244584
[TBL] [Abstract][Full Text] [Related]
7. Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice.
Shang Y; Mishra A; Wang T; Wang Y; Desai M; Chen S; Mao Z; Do L; Bernstein AS; Trouard TP; Brinton RD
PLoS One; 2020; 15(1):e0225392. PubMed ID: 31917799
[TBL] [Abstract][Full Text] [Related]
8. Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases.
Wang Y; Mishra A; Brinton RD
F1000Res; 2020; 9():. PubMed ID: 32047612
[TBL] [Abstract][Full Text] [Related]
9. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
Heininger K
Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
[TBL] [Abstract][Full Text] [Related]
10. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.
Yao J; Rettberg JR; Klosinski LP; Cadenas E; Brinton RD
Mol Aspects Med; 2011 Aug; 32(4-6):247-57. PubMed ID: 22024249
[TBL] [Abstract][Full Text] [Related]
11. Female Sex and Alzheimer's Risk: The Menopause Connection.
Scheyer O; Rahman A; Hristov H; Berkowitz C; Isaacson RS; Diaz Brinton R; Mosconi L
J Prev Alzheimers Dis; 2018; 5(4):225-230. PubMed ID: 30298180
[TBL] [Abstract][Full Text] [Related]
12. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
13. APOE and metabolic dysfunction in Alzheimer's disease.
Johnson LA
Int Rev Neurobiol; 2020; 154():131-151. PubMed ID: 32739002
[TBL] [Abstract][Full Text] [Related]
14. Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
Mosconi L; Berti V; Quinn C; McHugh P; Petrongolo G; Osorio RS; Connaughty C; Pupi A; Vallabhajosula S; Isaacson RS; de Leon MJ; Swerdlow RH; Brinton RD
PLoS One; 2017; 12(10):e0185926. PubMed ID: 29016679
[TBL] [Abstract][Full Text] [Related]
15. Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease.
Mishra A; Brinton RD
Front Aging Neurosci; 2018; 10():312. PubMed ID: 30356809
[TBL] [Abstract][Full Text] [Related]
16. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
Duarte AI; Santos MS; Oliveira CR; Moreira PI
Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
[TBL] [Abstract][Full Text] [Related]
17. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
18. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
Pardo JV; Lee JT;
eNeuro; 2018; 5(1):. PubMed ID: 29497704
[TBL] [Abstract][Full Text] [Related]
19. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.
Henderson VW; Brinton RD
Prog Brain Res; 2010; 182():77-96. PubMed ID: 20541661
[TBL] [Abstract][Full Text] [Related]
20. Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis.
Castro CB; Dias CB; Hillebrandt H; Sohrabi HR; Chatterjee P; Shah TM; Fuller SJ; Garg ML; Martins RN
Nutr Rev; 2023 Aug; 81(9):1144-1162. PubMed ID: 36633304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
